The University of Chicago Header Logo

Connection

Randy Sweis to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications Randy Sweis has written about Protein Kinase Inhibitors.
Randy Sweis
Connection Strength
0.141
Protein Kinase Inhibitors
  1. Lenvatinib plus pembrolizumab in patients with either treatment-naive or previously treated metastatic renal cell carcinoma (Study 111/KEYNOTE-146): a phase 1b/2 study. Lancet Oncol. 2021 07; 22(7):946-958.
    View in: PubMed
    Score: 0.141
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.